# Pilot Study to Assess Number of Patients for Main Trial

> **NCT02734628** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 28 (actual)

## Conditions studied

- Wound Healing

## Interventions

- **DRUG:** Dexpanthenol (Bepanthen® Wund- und Heilsalbe, BAY81-2996)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02734628
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2007-04
- **Final completion:** 2007-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2016-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02734628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02734628, "Pilot Study to Assess Number of Patients for Main Trial". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02734628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*